| HLS THERAPEUTICS INC. |
| Kanada |
| Gesundheit |
| CA40390B1094 / A2JGH0 |
| 74D (Frankfurt) |
| FRA:74D, ETR:74D, 74D:GR |
| - |
| http://www.hlstherapeutic.. |
|
HLS Therapeutics Inc. is a specialty pharmaceutical company focused on the acquisition and commercialization of late-stage development and commercial stage branded pharmaceutical products. Their primary mission is to enhance the quality of healthcare..
>Volltext.. |
| 85.07 Mio. EUR |
| 117.44 Mio. EUR |
| 48.91 Mio. EUR |
| 15.59 Mio. EUR |
| -10.99 Mio. EUR |
| -0.35 EUR |
| 43.08 Mio. EUR |
| 10.14 Mio. EUR |
| 13.88 Mio. EUR |
| 0.45 |
| -7.76% |
| 40.07% |
| - |
| - |
| - |
| 27.04.23 - 0.030594999€ 30.01.23 - 0.030594999€ >weitere anzeigen... |
| - |
| HLS THERAPEUTICS, HLS THERAPEUTIC |
| 05.04.26 |
|